Loading…

Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency

Mice with targeted deletion of the GABA catabolic enzyme succinic semialdehyde dehydrogenase (SSADH) manifest lethal tonic–clonic seizures, amenable to pharmacologic rescue, at 3–4 weeks of life. In the current report, we characterized amino acid profiles in SSADH −/− brain utilizing whole brain and...

Full description

Saved in:
Bibliographic Details
Published in:Neurobiology of disease 2004-08, Vol.16 (3), p.556-562
Main Authors: Gupta, M, Polinsky, M, Senephansiri, H, Snead, O.C, Jansen, E.E.W, Jakobs, C, Gibson, K.M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c446t-479282897e868daa900a22c78ddbfe87eea7eacdec80326ed899399b7e3987cb3
cites cdi_FETCH-LOGICAL-c446t-479282897e868daa900a22c78ddbfe87eea7eacdec80326ed899399b7e3987cb3
container_end_page 562
container_issue 3
container_start_page 556
container_title Neurobiology of disease
container_volume 16
creator Gupta, M
Polinsky, M
Senephansiri, H
Snead, O.C
Jansen, E.E.W
Jakobs, C
Gibson, K.M
description Mice with targeted deletion of the GABA catabolic enzyme succinic semialdehyde dehydrogenase (SSADH) manifest lethal tonic–clonic seizures, amenable to pharmacologic rescue, at 3–4 weeks of life. In the current report, we characterized amino acid profiles in SSADH −/− brain utilizing whole brain and regional extracts (frontal and parietal cortex, hippocampus, and cerebellum) to develop hypotheses concerning epileptogenesis. Of 35 amino acids quantified, we found significant dysregulation in SSADH −/− mice for 11 (GABA, glutamate, glutamine, alanine, aspartate, serine, taurine, cystathionine, methionine, homocarnosine, and arginine) as compared to age-matched littermates both before, and following, the period of generalized convulsive seizures and status epilepticus. Our results reveal imbalanced amino acid levels potentially involved in the transition from absence seizures to generalized convulsive seizures resulting in SSADH −/− mice. We conclude that the SSADH −/− mouse represents a unique epileptic model with the potential to reveal novel aspects of excitatory/inhibitory interactions in the genesis of seizures.
doi_str_mv 10.1016/j.nbd.2004.04.008
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f284c5118ba140f2b6b264e8591e3b00</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0969996104000981</els_id><doaj_id>oai_doaj_org_article_f284c5118ba140f2b6b264e8591e3b00</doaj_id><sourcerecordid>20537796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-479282897e868daa900a22c78ddbfe87eea7eacdec80326ed899399b7e3987cb3</originalsourceid><addsrcrecordid>eNqFkUuLFTEQhYMozp3RH-BGshJd9DVJd-eBq2F0nIEBF1fBXcijesylOxmT7oHrrzf3ge4UCioUXx0q5yD0ipI1JZS_366j9WtGSLfeF5FP0IoS1Teqb78_RSuiuGqU4vQMnZeyJYTSXonn6Iz2jDPGxQpNGwi_lgwYHtO4zCFFbKLHZgoxYeOCx2GyZjTRQcEh4mnJIQIui3Mhmrm-YApm9PBj5wEfWk73EE0B_Hazufx4865Oh-ACRLd7gZ4NZizw8tQv0LfrT1-vbpq7L59vry7vGtd1fG46oZhkUgmQXHpjFCGGMSek93YAKQCMAOM8OElaxsFLpVqlrIBWSeFse4Fuj7o-ma1-yGEyeaeTCfowSPlemzwHN4IemOxcT6m0hnZkYJZbxjuQvaLQWkKq1puj1kNOPxcos55CcTBWTyAtRXMuGOl491-Qkb4VQvEK0iPociolw_DnQkr0Pli91TVYvQ9W74vIuvP6JL7YCfzfjVOSFfhwBKD6-hgg63LwHHzI4Ob68fAP-d8B0LP2</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20537796</pqid></control><display><type>article</type><title>Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency</title><source>ScienceDirect Journals</source><creator>Gupta, M ; Polinsky, M ; Senephansiri, H ; Snead, O.C ; Jansen, E.E.W ; Jakobs, C ; Gibson, K.M</creator><creatorcontrib>Gupta, M ; Polinsky, M ; Senephansiri, H ; Snead, O.C ; Jansen, E.E.W ; Jakobs, C ; Gibson, K.M</creatorcontrib><description>Mice with targeted deletion of the GABA catabolic enzyme succinic semialdehyde dehydrogenase (SSADH) manifest lethal tonic–clonic seizures, amenable to pharmacologic rescue, at 3–4 weeks of life. In the current report, we characterized amino acid profiles in SSADH −/− brain utilizing whole brain and regional extracts (frontal and parietal cortex, hippocampus, and cerebellum) to develop hypotheses concerning epileptogenesis. Of 35 amino acids quantified, we found significant dysregulation in SSADH −/− mice for 11 (GABA, glutamate, glutamine, alanine, aspartate, serine, taurine, cystathionine, methionine, homocarnosine, and arginine) as compared to age-matched littermates both before, and following, the period of generalized convulsive seizures and status epilepticus. Our results reveal imbalanced amino acid levels potentially involved in the transition from absence seizures to generalized convulsive seizures resulting in SSADH −/− mice. We conclude that the SSADH −/− mouse represents a unique epileptic model with the potential to reveal novel aspects of excitatory/inhibitory interactions in the genesis of seizures.</description><identifier>ISSN: 0969-9961</identifier><identifier>EISSN: 1095-953X</identifier><identifier>DOI: 10.1016/j.nbd.2004.04.008</identifier><identifier>PMID: 15262267</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aldehyde Oxidoreductases - deficiency ; Aldehyde Oxidoreductases - genetics ; Amino Acids - metabolism ; Animals ; Brain - metabolism ; Brain - physiopathology ; Disease Models, Animal ; Disinhibition ; Epilepsy ; Epilepsy - physiopathology ; GABA ; gamma-Aminobutyric Acid - metabolism ; Gamma-hydroxybutyric acid ; Glutamic Acid - metabolism ; Glutamine ; Glutamine - metabolism ; Knockout ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Neural Inhibition ; Succinate-Semialdehyde Dehydrogenase ; Succinic semialdehyde dehydrogenase deficiency</subject><ispartof>Neurobiology of disease, 2004-08, Vol.16 (3), p.556-562</ispartof><rights>2004 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-479282897e868daa900a22c78ddbfe87eea7eacdec80326ed899399b7e3987cb3</citedby><cites>FETCH-LOGICAL-c446t-479282897e868daa900a22c78ddbfe87eea7eacdec80326ed899399b7e3987cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0969996104000981$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15262267$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gupta, M</creatorcontrib><creatorcontrib>Polinsky, M</creatorcontrib><creatorcontrib>Senephansiri, H</creatorcontrib><creatorcontrib>Snead, O.C</creatorcontrib><creatorcontrib>Jansen, E.E.W</creatorcontrib><creatorcontrib>Jakobs, C</creatorcontrib><creatorcontrib>Gibson, K.M</creatorcontrib><title>Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency</title><title>Neurobiology of disease</title><addtitle>Neurobiol Dis</addtitle><description>Mice with targeted deletion of the GABA catabolic enzyme succinic semialdehyde dehydrogenase (SSADH) manifest lethal tonic–clonic seizures, amenable to pharmacologic rescue, at 3–4 weeks of life. In the current report, we characterized amino acid profiles in SSADH −/− brain utilizing whole brain and regional extracts (frontal and parietal cortex, hippocampus, and cerebellum) to develop hypotheses concerning epileptogenesis. Of 35 amino acids quantified, we found significant dysregulation in SSADH −/− mice for 11 (GABA, glutamate, glutamine, alanine, aspartate, serine, taurine, cystathionine, methionine, homocarnosine, and arginine) as compared to age-matched littermates both before, and following, the period of generalized convulsive seizures and status epilepticus. Our results reveal imbalanced amino acid levels potentially involved in the transition from absence seizures to generalized convulsive seizures resulting in SSADH −/− mice. We conclude that the SSADH −/− mouse represents a unique epileptic model with the potential to reveal novel aspects of excitatory/inhibitory interactions in the genesis of seizures.</description><subject>Aldehyde Oxidoreductases - deficiency</subject><subject>Aldehyde Oxidoreductases - genetics</subject><subject>Amino Acids - metabolism</subject><subject>Animals</subject><subject>Brain - metabolism</subject><subject>Brain - physiopathology</subject><subject>Disease Models, Animal</subject><subject>Disinhibition</subject><subject>Epilepsy</subject><subject>Epilepsy - physiopathology</subject><subject>GABA</subject><subject>gamma-Aminobutyric Acid - metabolism</subject><subject>Gamma-hydroxybutyric acid</subject><subject>Glutamic Acid - metabolism</subject><subject>Glutamine</subject><subject>Glutamine - metabolism</subject><subject>Knockout</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Neural Inhibition</subject><subject>Succinate-Semialdehyde Dehydrogenase</subject><subject>Succinic semialdehyde dehydrogenase deficiency</subject><issn>0969-9961</issn><issn>1095-953X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFkUuLFTEQhYMozp3RH-BGshJd9DVJd-eBq2F0nIEBF1fBXcijesylOxmT7oHrrzf3ge4UCioUXx0q5yD0ipI1JZS_366j9WtGSLfeF5FP0IoS1Teqb78_RSuiuGqU4vQMnZeyJYTSXonn6Iz2jDPGxQpNGwi_lgwYHtO4zCFFbKLHZgoxYeOCx2GyZjTRQcEh4mnJIQIui3Mhmrm-YApm9PBj5wEfWk73EE0B_Hazufx4865Oh-ACRLd7gZ4NZizw8tQv0LfrT1-vbpq7L59vry7vGtd1fG46oZhkUgmQXHpjFCGGMSek93YAKQCMAOM8OElaxsFLpVqlrIBWSeFse4Fuj7o-ma1-yGEyeaeTCfowSPlemzwHN4IemOxcT6m0hnZkYJZbxjuQvaLQWkKq1puj1kNOPxcos55CcTBWTyAtRXMuGOl491-Qkb4VQvEK0iPociolw_DnQkr0Pli91TVYvQ9W74vIuvP6JL7YCfzfjVOSFfhwBKD6-hgg63LwHHzI4Ob68fAP-d8B0LP2</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Gupta, M</creator><creator>Polinsky, M</creator><creator>Senephansiri, H</creator><creator>Snead, O.C</creator><creator>Jansen, E.E.W</creator><creator>Jakobs, C</creator><creator>Gibson, K.M</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20040801</creationdate><title>Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency</title><author>Gupta, M ; Polinsky, M ; Senephansiri, H ; Snead, O.C ; Jansen, E.E.W ; Jakobs, C ; Gibson, K.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-479282897e868daa900a22c78ddbfe87eea7eacdec80326ed899399b7e3987cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aldehyde Oxidoreductases - deficiency</topic><topic>Aldehyde Oxidoreductases - genetics</topic><topic>Amino Acids - metabolism</topic><topic>Animals</topic><topic>Brain - metabolism</topic><topic>Brain - physiopathology</topic><topic>Disease Models, Animal</topic><topic>Disinhibition</topic><topic>Epilepsy</topic><topic>Epilepsy - physiopathology</topic><topic>GABA</topic><topic>gamma-Aminobutyric Acid - metabolism</topic><topic>Gamma-hydroxybutyric acid</topic><topic>Glutamic Acid - metabolism</topic><topic>Glutamine</topic><topic>Glutamine - metabolism</topic><topic>Knockout</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Neural Inhibition</topic><topic>Succinate-Semialdehyde Dehydrogenase</topic><topic>Succinic semialdehyde dehydrogenase deficiency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, M</creatorcontrib><creatorcontrib>Polinsky, M</creatorcontrib><creatorcontrib>Senephansiri, H</creatorcontrib><creatorcontrib>Snead, O.C</creatorcontrib><creatorcontrib>Jansen, E.E.W</creatorcontrib><creatorcontrib>Jakobs, C</creatorcontrib><creatorcontrib>Gibson, K.M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Neurobiology of disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, M</au><au>Polinsky, M</au><au>Senephansiri, H</au><au>Snead, O.C</au><au>Jansen, E.E.W</au><au>Jakobs, C</au><au>Gibson, K.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency</atitle><jtitle>Neurobiology of disease</jtitle><addtitle>Neurobiol Dis</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>16</volume><issue>3</issue><spage>556</spage><epage>562</epage><pages>556-562</pages><issn>0969-9961</issn><eissn>1095-953X</eissn><abstract>Mice with targeted deletion of the GABA catabolic enzyme succinic semialdehyde dehydrogenase (SSADH) manifest lethal tonic–clonic seizures, amenable to pharmacologic rescue, at 3–4 weeks of life. In the current report, we characterized amino acid profiles in SSADH −/− brain utilizing whole brain and regional extracts (frontal and parietal cortex, hippocampus, and cerebellum) to develop hypotheses concerning epileptogenesis. Of 35 amino acids quantified, we found significant dysregulation in SSADH −/− mice for 11 (GABA, glutamate, glutamine, alanine, aspartate, serine, taurine, cystathionine, methionine, homocarnosine, and arginine) as compared to age-matched littermates both before, and following, the period of generalized convulsive seizures and status epilepticus. Our results reveal imbalanced amino acid levels potentially involved in the transition from absence seizures to generalized convulsive seizures resulting in SSADH −/− mice. We conclude that the SSADH −/− mouse represents a unique epileptic model with the potential to reveal novel aspects of excitatory/inhibitory interactions in the genesis of seizures.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15262267</pmid><doi>10.1016/j.nbd.2004.04.008</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0969-9961
ispartof Neurobiology of disease, 2004-08, Vol.16 (3), p.556-562
issn 0969-9961
1095-953X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f284c5118ba140f2b6b264e8591e3b00
source ScienceDirect Journals
subjects Aldehyde Oxidoreductases - deficiency
Aldehyde Oxidoreductases - genetics
Amino Acids - metabolism
Animals
Brain - metabolism
Brain - physiopathology
Disease Models, Animal
Disinhibition
Epilepsy
Epilepsy - physiopathology
GABA
gamma-Aminobutyric Acid - metabolism
Gamma-hydroxybutyric acid
Glutamic Acid - metabolism
Glutamine
Glutamine - metabolism
Knockout
Mice
Mice, Inbred C57BL
Mice, Knockout
Neural Inhibition
Succinate-Semialdehyde Dehydrogenase
Succinic semialdehyde dehydrogenase deficiency
title Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A45%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seizure%20evolution%20and%20amino%20acid%20imbalances%20in%20murine%20succinate%20semialdehyde%20dehydrogenase%20(SSADH)%20deficiency&rft.jtitle=Neurobiology%20of%20disease&rft.au=Gupta,%20M&rft.date=2004-08-01&rft.volume=16&rft.issue=3&rft.spage=556&rft.epage=562&rft.pages=556-562&rft.issn=0969-9961&rft.eissn=1095-953X&rft_id=info:doi/10.1016/j.nbd.2004.04.008&rft_dat=%3Cproquest_doaj_%3E20537796%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c446t-479282897e868daa900a22c78ddbfe87eea7eacdec80326ed899399b7e3987cb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20537796&rft_id=info:pmid/15262267&rfr_iscdi=true